Clinical Trials

Neoplastic Cells, Circulating, Rectal Neoplasms

NCT07162714 2025-09-09

STAR

30 enrolled

Rectal Neoplasms

NCT04404777 2025-06-17

LERIS

Active not recruiting

12,000 enrolled

Rectal Neoplasms

NCT06908031 2025-05-14

CRIT

Phase 2 Recruiting

49 enrolled

Rectal Neoplasms

NCT06919510 2025-04-09

A Phase ll Study of Neoadjuvant Short-course Radiotherapy Followed by Ivonescimab and Chemotherapy in pMMR/MSS Locally Advanced Rectal Cancer

90 enrolled

Rectal Neoplasms

NCT06246344 2025-03-12

Adaptive Boost Radiotherapy to Primary Lesions and Positive Nodes in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer

Recruiting

128 enrolled

Rectal Neoplasms

NCT04503694 2025-03-05

REGINA

Phase 2 Recruiting

72 enrolled

Rectal Neoplasms

NCT06758830 2025-01-09

Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.

Phase 2/3 Recruiting

400 enrolled

Low Anterior Resection Syndrome, Fatigue, Postoperative Complications, Radiation Injuries, Rectal Neoplasms

NCT06751394 2024-12-27

TRACER

44 enrolled

Rectal Neoplasms

NCT05964530 2024-09-20

Radical vs Local Excision for Rectal Cancer With Clinically Complete Remission

Phase NA Recruiting

180 enrolled

Rectal Neoplasms

NCT06599827 2024-09-19

iMHRT-LARC

54 enrolled

Rectal Neoplasms

NCT00297791 2024-08-21

COLORII

Phase 3 Completed

1,044 enrolled

Phase 3 Active not recruiting

Rectal Neoplasms

NCT03879109 2024-08-14

GRECCAR15

58 enrolled

Rectal Neoplasms

NCT01515787 2024-02-02

PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery

Phase 2/3 Unknown

1,194 enrolled 25 charts

Rectal Neoplasms, Colorectal Neoplasms

NCT02363374 2023-12-04

CAOAROAIO-12

311 enrolled

Rectal Neoplasms

NCT03125343 2023-11-07

WoW

Phase NA Recruiting

400 enrolled

Pathologic Complete Response, Rectal Neoplasms

NCT06113796 2023-11-02

Economic Analysis of Robotic Rectal Resection in German Health Care System

Completed

65 enrolled

Phase 2 Active not recruiting

Rectal Neoplasms

NCT03840239 2023-10-25

TESS

98 enrolled

Rectal Neoplasms

NCT02017704 2023-10-17

CORRECT

9 enrolled 9 charts

Rectal Neoplasms

NCT05939661 2023-07-11

AMBITION

Phase 2 Recruiting

45 enrolled

Rectal Neoplasms

NCT01444495 2023-02-15

Randomized Clinical Trial on Preoperative Radiotherapy 25 Gy in Rectal Cancer

Phase NA Completed

154 enrolled

Rectal Neoplasms

NCT02910843 2023-01-10

RECAP

Phase 1 Terminated

25 enrolled

Rectal Neoplasms

NCT05671809 2023-01-05

ARF-RC

Not yet recruiting

402 enrolled

Rectal Neoplasms

NCT05201430 2022-03-04

RCNAC

Phase 3 Recruiting

300 enrolled

Rectal Neoplasms

NCT05108753 2021-11-05

Short-term Outcomes of Transanal Total Mesorectal Excision With Structured Training Curriculums in China

Completed

175 enrolled

Rectal Neoplasms

NCT04717947 2021-02-04

CRONOS

Unknown

911 enrolled

Rectal Neoplasms

NCT02010567 2020-11-03

Neoadjuvant Chemoradiotherapy With CRLX-101 and Capecitabine for Rectal Cancer

Phase 1/2 Terminated

32 enrolled 18 charts

Rectal Neoplasms, Colorectal Neoplasms

NCT01363843 2020-06-11

Complete Neoadjuvant Treatment for REctal Cancer (CONTRE)

39 enrolled 7 charts

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT04288999 2020-06-04

JCOG1801

Phase 3 Recruiting

110 enrolled

Rectal Neoplasms

NCT03258541 2020-05-15

Organ-sparing With TraceIT® for Rectal Cancer Radiotherapy

Phase NA Terminated

2 enrolled

Rectal Neoplasms

NCT03265418 2019-09-04

BioXmark, Rectal Feasibility Trial

Phase NA Completed

20 enrolled

Rectal Neoplasms

NCT01047969 2019-06-13

Avoiding Surgery in Rectal Cancer After Pre-Operative Therapy

Phase 2 Unknown

99 enrolled

Rectal Neoplasms

NCT00535041 2019-03-01

Pilot Trial of Pre-operative Chemo/RT Using Xeloda and External Beam RT Followed by Definite Surgery in Patients With Localized Rectal CA

Phase NA Completed

200 enrolled

Rectal Neoplasms

NCT02017509 2018-08-29

Immunoscore in Rectal Cancer

Completed

3 enrolled

Rectal Neoplasms

NCT00310076 2018-08-23

Thalidomide in Treating Patients Who Have Undergone Surgery and Chemotherapy for Cancer That Has Spread Throughout the Abdomen Due to Colorectal Cancer or Appendix Cancer

29 enrolled 9 charts

Appendiceal Neoplasms, Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT01749956 2017-02-07

5-FU, Aflibercept, and Radiation (RT) for Preoperative and Postoperative Patients With Stage II/III Rectal Cancer

39 enrolled 13 charts

Rectal Neoplasms

NCT00081224 2016-12-15

Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the Rectum

Phase 2 Terminated

3 enrolled

Rectal Neoplasms, Colorectal Neoplasms

NCT00216086 2016-06-06

Capecitabine + Irinotecan Followed by Combined Modality Capecitabine and Radiation in Locally Advanced Rectal Cancer

Phase 2 Terminated

22 enrolled 10 charts

Rectal Neoplasms

NCT01818973 2015-06-08

Preoporative Bevacizumab, Radiation Therapy, and XELOX Chemotherapy for Locally Advanced Nonmetastatic Rectal Cancer

Phase 2 Unknown

45 enrolled

Rectal Neoplasms

NCT00543842 2015-02-26

Bevacizumab, Erlotinib, and Capecitabine for Locally Advanced Rectal Cancer

Phase 1 Completed

19 enrolled

Rectal Neoplasms

NCT02268006 2014-10-20

BISER

Phase 2 Unknown

50 enrolled

Rectal Neoplasms

NCT00215956 2013-12-23

A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal Carcinoma

Phase 1 Completed

31 enrolled

Rectal Neoplasms

NCT00003544 2013-06-26

Irinotecan in Treating Patients With Metastatic Colorectal Cancer

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT01064999 2012-03-14

A Trial of High Intensity Versus Low Intensity Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

Phase 2/3 Unknown

240 enrolled

Rectal Neoplasms

NCT00176787 2008-01-10

Radiation Therapy With Capecitabine in Rectal Cancer

Phase 2 Terminated

30 enrolled